This company seems to have been delisted
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Catalent
CTLT
C$87.40
Share price
0.00%
Change (1 day)
13.12%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Catalent (CTLT) - Total assets
Total assets on the balance sheet as of September 2024 : C$13.36 Billion
According to Catalent's latest financial reports the company's total assets are C$13.36 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Catalent - Total assets on balance sheet (from 2013 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-06-30 | C$14.26 B | 5.44% |
| 2022-06-30 | C$13.52 B | 19.8% |
| 2021-06-30 | C$11.29 B | 6.97% |
| 2020-06-30 | C$10.55 B | 30.41% |
| 2019-06-30 | C$8.09 B | 35.87% |
| 2018-06-30 | C$5.95 B | 32.78% |
| 2017-06-30 | C$4.48 B | 12.03% |
| 2016-06-30 | C$4.00 B | 2.29% |
| 2015-06-30 | C$3.91 B | 18.74% |
| 2014-06-30 | C$3.29 B | 6.34% |
| 2013-06-30 | C$3.10 B | -2.98% |
| 2012-06-30 | C$3.19 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | C$1.85 B | -86.12% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | C$0.51 B | -96.13% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | C$15.88 B | 18.82% | 🇮🇪 Ireland |
 Intercept Pharmaceuticals
ICPT | C$0.54 B | -95.95% | 🇺🇸 USA |